FOX
33
-7
DHR
46
-3
SIG
41
-3
CFG
56
-2
MU
39
-3
BEN
33
-3
EXPD
40
-2
NVDA
60
-3
VTR
54
4
WU
12
2
AMG
38
-6
HAS
43
-2
ORCL
62
-3
CMS
60
2
KO
34
-2
T
53
9
JNJ
54
3
QRVO
34
-2
WYNN
41
-3
CVS
39
2
FOX
33
-7
DHR
46
-3
SIG
41
-3
CFG
56
-2
MU
39
-3
BEN
33
-3
EXPD
40
-2
NVDA
60
-3
VTR
54
4
WU
12
2
AMG
38
-6
HAS
43
-2
ORCL
62
-3
CMS
60
2
KO
34
-2
T
53
9
JNJ
54
3
QRVO
34
-2
WYNN
41
-3
CVS
39
2
Financhill
Back

Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings

Escape the market madness with 7 stocks to buy and hold

Get the complete list FREE for a limited time.
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
54.79
Seasonality Move:
12.42%

7 Day Trial

ALL ACCESS PASS

$ 7

The truth about AI stocks (must see)

Learn the names of all 10 stocks here. FREE.

Ultragenyx Pharmaceutical Price Quote

$54.79
+0.10 (+0.18%)
(Updated: October 24, 2024 at 4:00 PM ET)

Ultragenyx Pharmaceutical Key Stats

Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell
Day range:
$54.51 - $56.38
52-week range:
$31.52 - $60.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.21
P/B ratio:
11.68%
Volume:
516.7K
Avg. volume:
608.3K
1-year change:
70.91%
Market cap:
$5B
Revenue:
$434.2M
EPS:
$-7.3

How Much Does Ultragenyx Pharmaceutical Make?

Is Ultragenyx Pharmaceutical Growing As A Company?

Ultragenyx Pharmaceutical Stock Price Performance

What Is Ultragenyx Pharmaceutical 52-Week High & Low?

Ultragenyx Pharmaceutical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ultragenyx Pharmaceutical?

Is Ultragenyx Pharmaceutical Cash Flow Positive?

  • What Is RARE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$469.5M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $740.7M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $112.3M

Ultragenyx Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    RARE return on invested capital is -290%
  • What Is Ultragenyx Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is -42%
  • What Is RARE Return On Equity?
    ROE is a measure of profitability and is -290%

Ultragenyx Pharmaceutical Earnings Date & Stock Price

Ultragenyx Pharmaceutical Competitors

Ultragenyx Pharmaceutical Dividend Yield

Ultragenyx Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.9%
Revenue: 35.75% 19.33%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 91.57
Upside from Last Price: 67.44%

Major Shareholders

  • How many RARE shares are owned by institutional investors?
    134.7M RARE shares are owned by institutional investors
  • How many RARE shares are owned by insiders?
    1.8M RARE shares are owned by insiders